Hypogonadotropic Hypogonadism: Clinical Trials

38 trials for Hypogonadotropic Hypogonadism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

22 completed, 6 unknown, 5 terminated, 4 recruiting. 10 Phase 2, 9 Phase 1, 6 Not applicable, 5 Phase 4, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 210Completed 5, Recruiting 2, Terminated 2, Unknown 1
Phase 19Completed 8, Terminated 1
Not applicable6Unknown 4, Completed 1, Not yet recruiting 1
Phase 45Completed 2, Terminated 2, Unknown 1
Phase 33Completed 3

Follow Hypogonadotropic Hypogonadism: new trials by email Literature Review of Hypogonadotropic Hypogonadism trials Research Report on Hypogonadotropic Hypogonadism

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea
kisspeptin 112-121 - Hypothalamic Amenorrhea, Hypogonadotropic Hypogonadism
Phase 2RecruitingStephanie B. Seminara, MD202025-12-092026-07-13
Opioid Antagonism in Hypogonadotropic Hypogonadism
Naloxone - Hypogonadotropic Hypogonadism, Low Testosterone
Phase 1CompletedStephanie B. Seminara, MD232025-06-182026-06-03
Growing up With the Young Endocrine Support System (YESS!)
YESS! game, Snake '97, Transition-toolkit - Congenital Adrenal Hyperplasia, Hypogonadotropic Hypogonadism
Not applicableNot yet recruitingdr. Laura C. G. de Graaff-Herder1602024-12-012023-09-07
Assessment of Endometrial Thickness Among Adolescent and Young Adult Patients on Estrogen Replacement Therapy Using Daily Oral Micronized Progesterone Versus the Etonogestrel Implant.
Primary Ovarian Insufficiency, Hypogonadotropic Hypogonadism
RecruitingUniversity of Colorado, Denver342024-07-012024-12-06
Low Energy Availability and Pituitary Function (LEAP Study)
5-day controlled metabolic dietary intake - Hypogonadotropic Hypogonadism
Not applicableUnknownUniversity of Colorado, Denver252023-04-012023-04-11
Kisspeptin Administration Subcutaneously to Patients With IHH
kisspeptin 112-121, leuprolide acetate - Hypogonadotropic Hypogonadism
Phase 2RecruitingStephanie B. Seminara, MD362023-02-032026-07-13
Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders
Kisspeptin 112-121 - Hypothalamic Amenorrhea, Hypogonadotropic Hypogonadism
Phase 1CompletedStephanie B. Seminara, MD132022-12-162025-10-03
Efficacy of Prolonged GnRH Test in Male Adolescents With Postoperative HH
Gonadorelin - Hypogonadotropic Hypogonadism
Not applicableUnknownHuashan Hospital202022-01-012022-01-11
A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS Trial
Letrozole 2.5mg, hCG, Placebo - Hypogonadism, Hypogonadism, Male
Phase 4TerminatedCopenhagen University Hospital, Rigshospitalet82021-11-242024-02-15
The Molecular Basis of Inherited Reproductive Disorders
Hypogonadotropic Hypogonadism, Reproductive Disorder
CompletedStephanie B. Seminara, MD8542021-01-212026-07-13
A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism
Aveed Injectable Product, Fortesta, Testim - Hypogonadism, Hypogonadism, Male
Phase 4CompletedEndo USA Inc., a Keenova Therapeutics Company6732020-06-302025-03-14
Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism
kisspeptin 112-121, GnRH - Hypogonadotropic Hypogonadism
Phase 2CompletedStephanie B. Seminara, MD182019-05-032026-08-26
Hypothalamic-pituitary Dysfunction in Diabetes
Diagnostic testing - Diabete Mellitus, Hypogonadism
CompletedIstituto Auxologico Italiano2002018-05-252024-03-15
Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) (MK-8962-043)
Corifollitropin alfa, hCG - Hypogonadotropic Hypogonadism
Phase 3CompletedOrganon and Co172017-02-022024-05-23
A 6 Month Safety Extension Study of MBGS205
BGS649 - Hypogonadotropic Hypogonadism
Phase 2CompletedMereo BioPharma1432016-11-152023-05-18
Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin Treat Congenital Hypogonadotropic Hypogonadism
Human Menopausal Gonadotropin, Human Chorionic Gonadotropin - Kallmann Syndrome, Hypogonadotropic Hypogonadism
Phase 4UnknownBeijing Children's Hospital402016-08-012016-08-26
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
BGS649, Placebo - Hypogonadotropic Hypogonadism
Phase 2CompletedMereo BioPharma2712016-05-122022-09-14
Efficacy of Pulsatile GnRH Therapy on Male Patients With Pituitary Stalk Interruption Syndrome
Gonadotropin-releasing Hormone - Hypogonadotropic Hypogonadism
Not applicableUnknownPeking Union Medical College Hospital202016-01-012016-03-10
A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic Hypogonadism
TAK-448 - Hypogonadotropic Hypogonadism
Phase 2TerminatedTakeda152015-02-012017-03-31
Effect of Intranasal Insulin on LH Concentrations in Man
intranasal insulin, placebo (intranasal saline) - Hypogonadotropic Hypogonadism
Phase 1 / Phase 2CompletedTexas Tech University Health Sciences Center142014-12-012019-08-13

Showing 20 of 38. Sign in to see all of them.

Narrower conditions

Hypogonadism (38)  ·  Kallmann Syndrome (11)  ·  Idiopathic Hypogonadotropic Hypogonadism (4)  ·  Puberty, Delayed (3)  ·  Amenorrhea (2)  ·  Diabetes Mellitus (2)  ·  Eunuchism (2)  ·  Infertility (2)  ·  Insulin Resistance (2)  ·  Polycystic Ovary Syndrome (2)  ·  Puberty, Precocious (2)  ·  Addison Disease (1)  ·  Adrenal Hyperplasia, Congenital (1)  ·  Androgen-Insensitivity Syndrome (1)  ·  Anosmia (1)

Broader conditions

Endocrine System Diseases (38)  ·  Gonadal Disorders (38)  ·  Female Urogenital Diseases (14)  ·  Female Urogenital Diseases and Pregnancy Complications (14)  ·  Urogenital Diseases (14)  ·  Congenital Abnormalities (13)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (13)  ·  Disorders of Sex Development (13)  ·  Male Urogenital Diseases (13)  ·  Urogenital Abnormalities (13)  ·  Disorder of Sex Development, 46,XY (12)  ·  Genetic Diseases, Inborn (12)  ·  Nervous System Diseases (5)  ·  Brain Diseases (4)  ·  Central Nervous System Diseases (4)

Interventions

Gonadotropin-Releasing Hormone (9)  ·  Testosterone (4)  ·  Chorionic Gonadotropin (2)  ·  Clomiphene (2)  ·  Menotropins (2)  ·  Naloxone (2)  ·  follicle stimulating hormone, human, with HCG C-terminal peptide (2)  ·  Anastrozole (1)  ·  Diagnostic Techniques and Procedures (1)  ·  Glycoprotein Hormones, alpha Subunit (1)  ·  Letrozole (1)  ·  Leuprolide (1)  ·  Luteinizing Hormone, beta Subunit (1)  ·  Testosterone Propionate (1)  ·  Zinc (1)

Sponsors

Massachusetts General Hospital (9)  ·  Stephanie B. Seminara, MD (6)  ·  Mereo BioPharma (2)  ·  Organon and Co (2)  ·  University of Colorado, Denver (2)  ·  Amneal Pharmaceuticals, LLC (1)  ·  Beijing Children's Hospital (1)  ·  Centre Hospitalier Universitaire Vaudois (1)  ·  Centro Riproduzione e Andrologia (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  EMD Serono (1)  ·  Endo USA Inc., a Keenova Therapeutics Company (1)  ·  Federal University of São Paulo (1)  ·  Gulhane School of Medicine (1)  ·  Huashan Hospital (1)

Countries

United States (24)  ·  China (4)  ·  Italy (4)  ·  United Kingdom (3)  ·  Brazil (2)  ·  Denmark (2)  ·  Spain (2)  ·  Belgium (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Russia (1)  ·  South Africa (1)  ·  Switzerland (1)  ·  Turkey (Türkiye) (1)

Top investigators

Stephanie B Seminara, MD (6)  ·  Stephanie Seminara, MD (4)  ·  Hugh Jones (2)  ·  Janet E Hall, M.D. (2)  ·  Ann E Caldwell, PhD (1)  ·  Caroline Michaela Kistorp, professor, MD (1)  ·  Chunxiu Gong, doctor (1)  ·  Coskun Meric (1)  ·  David Hernandez (1)  ·  Julio Abucham, MD, PhD (1)  ·  Laura CG de Graaff, MD PhD (1)  ·  Lawrence Galitz, MD (1)

Results publications

PMID 31132118, PMID 21209029, PMID 23643382, PMID 29669934, PMID 32034419, PMID 11788640, PMID 12213860, PMID 12788881, PMID 14573733, PMID 15613419, PMID 16606836, PMID 16757106, PMID 16764984, PMID 17074994, PMID 17334928, PMID 17761590, PMID 17959774, PMID 18272894, PMID 19021638, PMID 19567835, PMID 20332248, PMID 20484732, PMID 20696889, PMID 21037178, PMID 2122732, PMID 21247312, PMID 21700882, PMID 22072740, PMID 22319038, PMID 22745237, PMID 22773735, PMID 23095369, PMID 23341491, PMID 23378218, PMID 23533228, PMID 24476074, PMID 2502554, PMID 25131486, PMID 25226293, PMID 25394172, PMID 25825944, PMID 28270212, PMID 28368443, PMID 28368486, PMID 30515210, PMID 3096182, PMID 3098771, PMID 32232399, PMID 32870266, PMID 33813517

NIH funding

U54HD028138 (2), 2014 (1), 2015 (1), R37HD043341 (1)